Stem Cell Transplant Superior to Meds for Secondary Progressive MS

Autologous hematopoietic stem cell transplant is linked to less disability and lower relapse rates than other disease-modifying therapies for patients with secondary progressive multiple sclerosis.
Medscape Medical News